Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513078 · ClinicalTrials.gov registry record · NA
Different Types of Cupping Therapy and Ankle Range of Motion
A NA study, sponsored by Northern Michigan University.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT06513078: Completed NA study, sponsored by Northern Michigan University.
NCT06513078 is a NA study that has completed, run by Northern Michigan University. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06513078, a NA study, has completed, sponsored by Northern Michigan University.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study was to determine the acute effects of different manual cupping therapy protocols on ankle range of motion, compared to sham treatments, in generally healthy adults with limited ankle range of motion (i.e., ankle dorsiflexion less than 40 degrees).
Primary Outcome
Weight bearing ankle dorsiflexion measured by performing a modified lunge and bringing the knee forward as far as possible without allowing the heel to come off of the ground. A digital inclinometer was placed vertically over the tibial tuberosity and the measurement was reported as the average of three trials, in degrees.
Interventions
- OTHER Static cupping
- OTHER Static sham cupping
- OTHER Dynamic cupping
- OTHER Dynamic sham cupping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2023-03-31 |
| Phase | NA |
What the finished NCT06513078 record still lists
NCT06513078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Static cupping is the first listed.
NCT06513078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06513078 about?
NCT06513078 is a clinical study titled "Different Types of Cupping Therapy and Ankle Range of Motion". The purpose of this study was to determine the acute effects of different manual cupping therapy protocols on ankle range of motion, compared to sham treatments, in generally healthy adults with limited ankle range of motion (i.e., ankle dorsiflexion less than 40 degrees).
What is the current status of trial NCT06513078?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2022-04-01. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT06513078?
The interventions under investigation include: Static cupping (OTHER), Static sham cupping (OTHER), Dynamic cupping (OTHER), Dynamic sham cupping (OTHER).
Who is sponsoring clinical trial NCT06513078?
This trial is sponsored by Northern Michigan University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06513078's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI